Cancer Progress and Priorities: Lung Cancer
- PMID: 31575553
- PMCID: PMC6777859
- DOI: 10.1158/1055-9965.EPI-19-0221
Cancer Progress and Priorities: Lung Cancer
Abstract
In the United States, lung cancer is the second most common diagnosed cancer and the leading cause of cancer-related death. Though tobacco smoking is the major risk factor accounting for 80 to 90% of all lung cancer diagnoses, there are numerous other risk factors that have been identified as casually associated with lung cancer etiology. However, there are few causally-linked risk factors for lung cancer diagnosed among never smokers which, if considered a unique reportable category, is the 11th most common cancer and the 7th leading cause of cancer-related death. Lung cancer survival has only marginally improved over the last several decades, but the availability of screening and early detection by low-dose computer tomography and advances in targeted treatments and immunotherapy will likely decrease mortality rates and improve patient survival outcomes in the near future.
Figures
Similar articles
-
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.Mayo Clin Proc. 2019 Aug;94(8):1623-1640. doi: 10.1016/j.mayocp.2019.01.013. Mayo Clin Proc. 2019. PMID: 31378236 Review.
-
Patient, tumor, and healthcare factors associated with regional variability in lung cancer survival: a Spanish high-resolution population-based study.Clin Transl Oncol. 2019 May;21(5):621-629. doi: 10.1007/s12094-018-1962-9. Epub 2018 Oct 19. Clin Transl Oncol. 2019. PMID: 30341474
-
Healthy volunteer effect in a lung cancer screening study.Eur J Cancer Prev. 2015 Sep;24(5):454. doi: 10.1097/CEJ.0000000000000110. Eur J Cancer Prev. 2015. PMID: 26214089 No abstract available.
-
Improving lung cancer survival; time to move on.BMC Pulm Med. 2012 Dec 13;12:77. doi: 10.1186/1471-2466-12-77. BMC Pulm Med. 2012. PMID: 23234250 Free PMC article.
-
Neoplasms of the lung.Curr Opin Pulm Med. 1999 Jul;5(4):185-8. doi: 10.1097/00063198-199907000-00001. Curr Opin Pulm Med. 1999. PMID: 10407684 Review. No abstract available.
Cited by
-
Metabolic reprogramming-driven homologous recombination and TCA cycle dysregulation contribute to poor prognoses in lung adenocarcinoma.J Cell Mol Med. 2024 Jun;28(11):e18406. doi: 10.1111/jcmm.18406. J Cell Mol Med. 2024. PMID: 38822457 Free PMC article.
-
Enhancing Lung Cancer Care in Portugal: Bridging Gaps for Improved Patient Outcomes.J Pers Med. 2024 Apr 24;14(5):446. doi: 10.3390/jpm14050446. J Pers Med. 2024. PMID: 38793028 Free PMC article. Review.
-
Analysis of Selected Toll-like Receptors in the Pathogenesis and Advancement of Non-Small-Cell Lung Cancer.J Clin Med. 2024 May 9;13(10):2793. doi: 10.3390/jcm13102793. J Clin Med. 2024. PMID: 38792335 Free PMC article.
-
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience.Diagnostics (Basel). 2024 May 15;14(10):1024. doi: 10.3390/diagnostics14101024. Diagnostics (Basel). 2024. PMID: 38786322 Free PMC article.
-
[Research Progress of the Effect of Mediterranean Diet on the Correlation of Lung Cancer].Zhongguo Fei Ai Za Zhi. 2024 Apr 20;27(4):299-305. doi: 10.3779/j.issn.1009-3419.2024.106.09. Zhongguo Fei Ai Za Zhi. 2024. PMID: 38769833 Free PMC article. Review. Chinese.
References
-
- American Cancer Society. Global Cancer Facts & Figures 4th Edition. Atlanta: American Cancer Society; 2018.
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68:394–424. - PubMed
-
- American Cancer Society. Cancer Facts & Figures 2019. Atlanta: American Cancer Society; 2019.
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69:7–34. - PubMed
-
- Rami-Porta R, Bolejack V, Giroux DJ, Chansky K, Crowley J, Asamura H, et al. The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2014; 9:1618–1624. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical